A. Sinclair Dunlop, Director at Apellis Pharmaceuticals, holds 339.37K shares in Apellis Pharmaceuticals (Ticker: APLS). Most recently, A. Sinclair Dunlop Bought $1,500 shares of Apellis Pharmaceuticals on Apr 15, 2024 for an estimated value of 19.79K.